People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| scPharmaceuticals Inc. | — | Pharmaceuticals | Series C | $71.8M | $1.6B | 2016 |
Dorothy Coleman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dorothy Coleman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kush Parmar | 1 | 10 |
| Jonathan Silverstein | 1 | 10 |
| Mette Kirstine Agger | 1 | 6 |
| Troy Ignelzi | 1 | 3 |
| Pieter Muntendam | 1 | 2 |
| Jack Khattar | 1 | 1 |
| Mette Agger | 1 | 1 |
| Abhay Gandhi | 1 | 1 |
| Dorothy Kirstine Coleman | 1 | 1 |
| Leonard Kirstine Schaeffer | 1 | 1 |
| Leonard Schaeffer | 1 | 1 |
| Abraham Ceesay | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.